SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-674229
Filing Date
2016-08-08
Accepted
2016-08-08 07:05:33
Documents
3
Period of Report
2016-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d237265d8k.htm 8-K 12537
2 EX-99.1 d237265dex991.htm EX-99.1 695380
3 GRAPHIC g237265horizon.jpg GRAPHIC 4464
  Complete submission text file 0001193125-16-674229.txt   715467
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Pharma plc (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 272179987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 161812476
SIC: 2834 Pharmaceutical Preparations